All News

A new Institute of Medicine report warns that we need to train all our health professionals in geriatrics in preparation for the aging of our population.

The Centers for Medicare & Medicaid Services has proposed new preventable conditions for which they won't pay hospitals and new reporting requirements for quality measures.

Rx to OTC drug switches are forecast to increase in the coming years, according to a new study by Kalorama.

WellPoint's HealthCore subsidiary is building a drug safety system called Safety Sentinel System in collaboration with FDA and top academic institutions.

The Coalition Against Insurance Fraud has issued a report about the harmful effects of insurance fraud and what actions can be taken to prevent it from occurring.

Regadenoson receives FDA approval as first A2A adenosine receptor agonist for myocardial perfusion imaging.

New organization seeks to improve dignity, self-respect & integrity for pharmacy employees by focusing on improving workplace conditions.

Medicare Part D beneficiaries will see a 7.5% increase in costs in 2009.

FDA issues an early warning of progressive multifocal leukoencephalopathy associated with mycophenolate mofetil and mycophenolic acid.

The Joint Commission has issued some specific recommendations to hospitals in an effort to protect kids from drug errors.

What are the criteria necessary for insulin pump coverage? Here are some clues.

Insmed has received a questionnaire from House of Representatives' Subcommittee on Health on develdoping legislation to establish a follow-on biologics regulatory pathway.

The growth of Indian generic companies.

This article for the generic supplement highlights findings of an exclusive survey conducted by Advanstar for Drug Topics.

This story addresses the issue of E-prescibing and generic utilization.

Gary Buehler is the subject of this question and answer style article that addresses issues pertinent to the generic industry.

Generic injectable products are coming into the market. This article details the flood of new entrants.

Here is a listing of the top 20 drug firms based on their retail sales for 2007.

The recent FDA voluntary withdrawal of cough and cold OTCs for infants has created a void that pharmacists should fill with patient counseling.

A review of the pathogenesis and clinical presentation of an HIV infection; methods of detection and diagnosis, and latest medications approved for the treatment of HIV / AIDS.

American Pharmacists Association and the NACDS Foundation launch MTM Version 2.0, an improved model for medication therapy management programs.

CVS Caremark has reached a settlement agrement with Department of Jutice to resolve an investigation into the practice of dispensing the generic ranitidine in capsule rather than tablet form

Medicare Part B has expanded coverage for warfarin patients monitoirng clotting time at home.

Bendamustine has been approved by the FDA for the treatment of CLL

The feds have released the pricing for durable medical equipment, prosthetics, orthotics, and supplies for the first round of competitive bidding

CMS will require Medicare Advantage annd prescription drug plan sponsors in the Medicare Part D program, cover more HIV retrovirals, include more MTM data, and specify prior authorization requirements.

Walgreens is launching health and wellness division to expand into worksite health clinics and has acquired two companies, I-trax and Whole Health Management of Cleveland.

The Centers for Medicare and Medicaid Services has issued a new definition of multi-source drugs